Equities

Imaging Dynamics Co Ltd

IDYLF:PKC

Imaging Dynamics Co Ltd

Actions
  • Price (USD)0.03
  • Today's Change0.00 / 0.00%
  • Shares traded45.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Mar 11 2024 13:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Imaging Dynamics Company Ltd. is a Canada-based manufacturer of medical imaging devices. The Company is a global medical imaging technology provider in the field of digital radiography (DR). DR is a form of x-ray imaging which replaces conventional film-based diagnostic imaging and provides a solution for medical facilities of all sizes to provide diagnostic x-ray images with the use of flat panel detectors to enhance the digital image quality and improve the level of healthcare for their patients. Its configuration of the charge coupled device (CCD) detector has synergized high resolution direct digital imaging for x-ray purposes. The DR products the Company offers include Medical CCD Detectors, Medical Flat Panel Detectors, multifunction X-ray machines, Veterinary X-ray machines. Magellan medical image processing software is its medical x-ray image processing software. Sirius Veterinary image processing software is its x-ray image processing software.

  • Revenue in CAD (TTM)103.65k
  • Net income in CAD-1.02m
  • Incorporated1995
  • Employees23.00
  • Location
    Imaging Dynamics Co Ltd110 Macintosh Blvd, Unit 2CONCORD L4K 4P3CanadaCAN
  • Phone+1 (403) 251-9939
  • Fax+1 (403) 251-1771
  • Websitehttp://www.imagingdynamics.com
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.